Aditxt, Inc. (NASDAQ:ADTX – Get Free Report) shares were up 45% on Wednesday . The stock traded as high as $2.72 and last traded at $2.32. Approximately 30,538,338 shares changed hands during mid-day trading, an increase of 6,795% from the average daily volume of 442,929 shares. The stock had previously closed at $1.60.
Aditxt Stock Up 45.0 %
The company has a fifty day simple moving average of $1.78 and a two-hundred day simple moving average of $2.95.
Aditxt (NASDAQ:ADTX – Get Free Report) last announced its quarterly earnings results on Monday, May 20th. The company reported ($9.14) earnings per share for the quarter, missing analysts’ consensus estimates of ($3.33) by ($5.81). Aditxt had a negative net margin of 5,016.31% and a negative return on equity of 927.61%.
About Aditxt
Aditxt, Inc, a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues.
Featured Stories
- Five stocks we like better than Aditxt
- What is a Dividend King?
- Real Estate Stock Signals a Boom in Manufacturing Activity
- The 3 Best Blue-Chip Stocks to Buy Now
- This Medical Giant’s Stock Rebounds: A 15% Upside Is the Minimum
- Stock Splits, Do They Really Impact Investors?
- Financial Giant’s Shares Soar on EPS Beat and Record Asset Levels
Receive News & Ratings for Aditxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aditxt and related companies with MarketBeat.com's FREE daily email newsletter.
